Vall Hebron Institute of Oncology (VHIO)
Contacto correo-e:rrhh@vhio.net
---
The group of Joan Seoane within the Vall d’Hebron Institute of Oncology,
Barcelona, is looking for a post-doctoral research fellow.
Our main field of interest is the understanding of the molecular mechanisms involved in the genesis and progression of glioma.
Glioma is the most common and aggressive tumour of the brain and its
most malignant form, glioblastoma multiforme. The understanding of the
molecular mechanisms involved in the biology of glioma is essential for
the development of successful and rational therapeutic strategies. Our
approach is based on a tight collaboration with clinical researchers of
the Vall d’Hebron hospital and the study of patient-derived tumours. We
analyse human biopsies, generate primary cultures of human tumour cells,
isolate the stem-cell-like population of patient-derived gliomas and
generate mouse models for glioma based on the orthotopical inoculation
of human glioma stem cells in the mouse brain to generate tumours with
the same characteristics as the original human tumour. Moreover, we
participate in ongoing clinical trials obtaining critical information
about the biology of human tumours. We expect that our results will help
understand the biology of glioma and cancer, and we aspire to tran
slate our discoveries to a clinical ambit identifying molecular markers
of diagnosis and prognosis, markers of response to therapies, and
unveil new therapeutic targets against this deadly disease.
Postdoctoral candidates must have a strong background in molecular and
cellular biology, at least one article as first author, and high
motivation.
The application will be open until the position is filled.
Interested candidates, please send a letter of intention, CV, and two references to
Human Resources (rrhh@vhio.net)
Información complementaria de la oferta:
Selected references related to the field:
S. Peñuelas, J. Anido, R. M. Prieto-Sánchez, G. Folch, I. Barba, I.
Cuartas, D. García-Dorado, M. A. Poca, J. Sahuquillo, J. Baselga, J.
Seoane “TGF-beta increases glioma-initiating cell self-renewal through
the induction of LIF in human glioblastoma” Cancer Cell (2009) 15,
315-327
A. Bruna, R.S. Darken, F. Rojo, A. Ocaña, S. Peñuelas, A. Arias, R.
Paris, A. Tortosa, J. Mora, J. Baselga, J. Seoane, “High TGFbeta-Smad
activity confers poor prognosis in glioma patients and promotes cell
proliferation depending on the methylation of the PDGF-B gene” Cancer
Cell (2007) 11, 147-160
No comments:
Post a Comment